Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2024 Mar 29:29:18.
doi: 10.4103/jrms.jrms_318_23. eCollection 2024.

First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults

Affiliations

First Iranian guidelines for the diagnosis, management, and treatment of hyperlipidemia in adults

Fahimeh Bagheri Kholenjani et al. J Res Med Sci. .

Abstract

This guideline is the first Iranian guideline developed for the diagnosis, management, and treatment of hyperlipidemia in adults. The members of the guideline developing group (GDG) selected 9 relevant clinical questions and provided recommendations or suggestions to answer them based on the latest scientific evidence. Recommendations include the low-density lipoprotein cholesterol (LDL-C) threshold for starting drug treatment in adults lacking comorbidities was determined to be over 190 mg/dL and the triglyceride (TG) threshold had to be >500 mg/dl. In addition to perform fasting lipid profile tests at the beginning and continuation of treatment, while it was suggested to perform cardiovascular diseases (CVDs) risk assessment using valid Iranian models. Some recommendations were also provided on lifestyle modification as the first therapeutic intervention. Statins were recommended as the first line of drug treatment to reduce LDL-C, and if its level was high despite the maximum allowed or maximum tolerated drug treatment, combined treatment with ezetimibe, proprotein convertase subtilisin/kexin type 9 inhibitors, or bile acid sequestrants was suggested. In adults with hypertriglyceridemia, pharmacotherapy with statin or fibrate was recommended. The target of drug therapy in adults with increased LDL-C without comorbidities and risk factors was considered an LDL-C level of <130 mg/dl, and in adults with increased TG without comorbidities and risk factors, TG levels of <200 mg/dl. In this guideline, specific recommendations and suggestions were provided for the subgroups of the general population, such as those with CVD, stroke, diabetes, chronic kidney disease, elderly, and women.

Keywords: Adult; Iran; clinical practice guideline; hyperlipidemia.

PubMed Disclaimer

Conflict of interest statement

There are no conflicts of interest.

Figures

Figure 1
Figure 1
Analytical framework for the management of dyslipidemia in adults. LDL-C = Low-density lipoprotein cholesterol; CVDs = Cardiovascular diseases; TG = Triglyceride
Figure 2
Figure 2
The algorithm for the diagnosis, management, and treatment of adult with high low-density lipoprotein cholesterol. LDL-C = Low-density lipoprotein cholesterol
Figure 3
Figure 3
The algorithm for the diagnosis, management, and treatment of adult with high triglyceride. *In this guideline, diabetes (type 1 and 2), cardiovascular diseases, ischemic stroke, familial hypercholesterolemia, and non-alcoholic fatty liver have been considered. CVDs = Cardiovascular diseases; TG = Triglyceride; ALT = Alanine transaminase

Similar articles

References

    1. Hill MF, Bordoni B. StatPearls [Internet] Treasure Island (FL): StatPearls Publishing; 2023. Hyperlipidemia.
    1. Grundy SM, Arai H, Barter P, Bersot TP, Betteridge DJ, Carmena R, et al. An international atherosclerosis society position paper: Global recommendations for the management of dyslipidemia: Executive summary. Atherosclerosis. 2014;232:410–3. - PubMed
    1. Tabatabaei-Malazy O, Qorbani M, Samavat T, Sharifi F, Larijani B, Fakhrzadeh H. Prevalence of dyslipidemia in Iran: A systematic review and meta-analysis study. Int J Prev Med. 2014;5:373–93. - PMC - PubMed
    1. Hovsepian S, Kelishadi R, Djalalinia S, Farzadfar F, Naderimagham S, Qorbani M. Prevalence of dyslipidemia in Iranian children and adolescents: A systematic review. J Res Med Sci. 2015;20:503–21. - PMC - PubMed
    1. Husain MJ, Spencer G, Nugent R, Kostova D, Richter P. The cost-effectiveness of hyperlipidemia medication in low- and middle-income countries: A review. Glob Heart. 2022;17:18. - PMC - PubMed